Page last updated: 2024-08-23

razoxane and Left Ventricular Dysfunction

razoxane has been researched along with Left Ventricular Dysfunction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franco, VI; Harake, D; Henkel, JM; Lipshultz, SE; Miller, TL1
Calvé, A; Chalifour, LE; Noiles, W; Sebag, IA1
Bengala, C; Carnino, F; Conte, P; Del Mastro, L; Gallo, L; Lionetto, R; Michelotti, A; Montanaro, E; Rosso, R; Tibaldi, C; Venturini, M1

Reviews

1 review(s) available for razoxane and Left Ventricular Dysfunction

ArticleYear
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.
    Future cardiology, 2012, Volume: 8, Issue:4

    Topics: Adiponectin; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antioxidants; Carbazoles; Cardiolipins; Cardiotonic Agents; Carvedilol; Doxorubicin; Erythropoietin; Heart; Heart Diseases; Humans; Lipid Peroxidation; Liposomes; Neoplasms; Piperazines; Propanolamines; Purines; Razoxane; Risk Factors; Sildenafil Citrate; Sulfones; Survivors; Ventricular Dysfunction, Left

2012

Trials

1 trial(s) available for razoxane and Left Ventricular Dysfunction

ArticleYear
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
    Breast cancer research and treatment, 2000, Volume: 59, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiovascular Agents; Epirubicin; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Razoxane; Treatment Outcome; Ventricular Dysfunction, Left

2000

Other Studies

1 other study(ies) available for razoxane and Left Ventricular Dysfunction

ArticleYear
The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:11

    Topics: Animals; Antineoplastic Agents; Calcium-Binding Proteins; Calsequestrin; Cardiotonic Agents; Cardiotoxins; Doxorubicin; Female; Heart Ventricles; Infertility, Female; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Razoxane; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling; Weaning

2012